Winsantor

Winsantor

Ensuring no one suffers from Peripheral Neuropathy

Print
Security Type
SAFE
Categories
Other
Min Investment
$500
Location
San Diego, CA
Offering Date
September 24, 2018
Expected Close Date
March 20, 2019
Target Raise
$1.07M
Deal Notes

Future Equity (Wefunder SAFE)

$70Mvaluation cap

25%discount

$25K+pro rata right threshold

A SAFE gives you the right to future shares in the company. If you invest, you're betting the company will be worth more than $70M in the future.

Company Description

WinSanTor is a clinical-stage company focused on developing drugs to treat diabetic peripheral neuropathy.

Perks

$1,000+
Access to our Investor Newsletter

$100,000+
Dinner with the WinSanTor team

Use of Proceeds

If we raise: $300,000

95% for drug manufacturing, 5% for Wefunder fees

 

If we raise: $1,070,000

35% towards drug manufacturing for clinical trials, 35% for toxicity trials to initiate studies in US, 25% for automating review of biological samples, 5% for Wefunder fees

Management Team / Advisory Board Bios

Stanley Kim - CEO
First two companies acquired by Qualcomm and Apple.

Nigel Calcutt - Co-Founder
Prof. of Pathology- UC San Diego, Lead Preclinical Contractor- NIH NIDDK-RAID, Expert in Neuropathy

Paul Fernyhough - Co-Founder
Professor in Pharmacology & Therapeutics at University of Manitoba, 20+ years in diabetic neuropathy

Lakshmi P. Kotra - Co-Founder
Director at Center for Molecular Design and Preformulations at UHN, Expertise in drug development

Deal Notes

Future Equity (Wefunder SAFE)

$70Mvaluation cap

25%discount

$25K+pro rata right threshold

A SAFE gives you the right to future shares in the company. If you invest, you're betting the company will be worth more than $70M in the future.

Amount Raised : $579,049
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A SAFE is an agreement between you—the investor—and the company in which the company promises to give you a future equity stake based on the amount you invested. It also involves some kind of a triggering event that must take place in order for you to get your future equity stake. Be careful as you may only get equity if a particular event is triggered.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments